Tech Company Financing Transactions
Phreesia Funding Round
Phreesia, based in New York, secured $4 million in funding from VantagePoint Capital Partners.
Transaction Overview
Company Name
Announced On
9/28/2010
Transaction Type
Venture Equity
Amount
$4,000,000
Round
Series D
Investors
VantagePoint Capital Partners (Eve Kurtin)
Proceeds Purpose
This investment will enable Phreesia to continue to expand its presence in the healthcare market so as to provide additional clinical value and increase revenue for clinicians across all 50 states.
Company Information
Company Status
Publicly-held
Industry
Healthcare Services
Mailing Address
432 Park Ave. South 12th Floor
New York, NY 10016
USA
New York, NY 10016
USA
Phone
Website
Email Address
Overview
Phreesia's (NYSE: PHR) automated patient intake platform provides an individualized experience designed to engage patients in their care and give you the capacity to do more of what matters in your organization.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Chaim Indig
Chief Financial Officer
Thomas Altier
VP - Customer Service
Evan Roberts
VP - Engineering
Daniel Nathan
VP - Human Resources
Amy VanDuyn
VP - Marketing
Michael Davidoff
VP - Sales
William Rideout
Browse more venture capital transactions:
Prev: 9/28/2010: Slate Pharmaceuticals venture capital transaction
Next: 9/28/2010: Group Price venture capital transaction
Share this article
Where The Data Comes From
We record every notable VC transaction. VC investment data records reported here are sourced from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs